FibroBiologics, Inc. received notice on December 30, 2025, that Nasdaq plans to delist its shares due to failing to meet the $1 minimum bid requirement for 30 consecutive days. The company will request a hearing to appeal this decision and has proposed a reverse stock split to regain compliance.